Thymogen

Research Phase

Thymogen (Glu-Trp Dipeptide)

Aliases
Glu-Trp, L-glutamyl-L-tryptophan
Administration
Intramuscular injection, Intranasal

Documented benefits

Tier 1 · Peer-reviewed / regulatory

Benefit categories

Immune & Inflammatory

Thymogen's defining research application — a minimal, synthetic dipeptide alternative within the same Russian bioregulatory peptide tradition as Thymalin.

Immune system strengthening

Its core, defining mechanism — supporting T-lymphocyte differentiation with a much simpler two-amino-acid structure than the whole-extract Thymalin.

Enhanced T-cell function

Studied for normalizing T-cell ratios and function, similar in research intent to Thymalin and Thymosin Alpha-1.